|
gptkbp:instance_of
|
gptkb:chemical_compound
|
|
gptkbp:administered_by
|
injection
|
|
gptkbp:affects
|
androgen receptors
mood swings
|
|
gptkbp:application
|
gptkb:sports_championship
|
|
gptkbp:associated_with
|
muscle recovery
increased aggression
|
|
gptkbp:available_in
|
black market
|
|
gptkbp:benefits
|
increased muscle mass
|
|
gptkbp:bioavailability
|
high
|
|
gptkbp:can_cause
|
acne
gynecomastia
|
|
gptkbp:can_lead_to
|
cardiovascular issues
hair loss
|
|
gptkbp:casnumber
|
123456-78-9
|
|
gptkbp:chemical_formula
|
C20 H30 N2 O3
|
|
gptkbp:class
|
anabolic agent
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:composed_by
|
gptkb:chemical_compound
|
|
gptkbp:controversy
|
doping in sports
|
|
gptkbp:developed_by
|
research laboratories
|
|
gptkbp:discovered_by
|
2010s
|
|
gptkbp:dissolved
|
soluble in organic solvents
|
|
gptkbp:enhances
|
athletic performance
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:financial_stability
|
stable under normal conditions
|
|
gptkbp:future_prospects
|
weight loss
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
RD-501
|
|
gptkbp:increased
|
endurance
|
|
gptkbp:influences
|
metabolic rate
protein synthesis
muscle hypertrophy
|
|
gptkbp:initiated_by
|
myostatin
|
|
gptkbp:invention
|
patented
|
|
gptkbp:investment
|
hormonal imbalance
|
|
gptkbp:is_a_derivative_of
|
testosterone
|
|
gptkbp:is_compared_to
|
other anabolic steroids
|
|
gptkbp:is_subject_to
|
anti-doping regulations
|
|
gptkbp:legal_status
|
varies by country
|
|
gptkbp:lifespan
|
approximately 12 hours
|
|
gptkbp:marketed_as
|
various brand names
performance-enhancing drug
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:not_approved_by
|
gptkb:FDA
|
|
gptkbp:notable_users
|
gptkb:athletes
|
|
gptkbp:notable_work
|
promising
|
|
gptkbp:potential_interactions
|
other medications
|
|
gptkbp:potentially_addictive
|
yes
|
|
gptkbp:previous_name
|
(2 S)-2-[(2 S)-1-[(2 S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]propanamide
|
|
gptkbp:reduces
|
fatigue
|
|
gptkbp:related_to
|
gptkb:anabolic_steroids
|
|
gptkbp:requires
|
medical supervision
|
|
gptkbp:research_focus
|
performance enhancement
|
|
gptkbp:scientific_classification
|
a controlled substance
|
|
gptkbp:side_effect
|
potential liver damage
|
|
gptkbp:structure
|
steroid nucleus
|
|
gptkbp:suitable_for
|
gptkb:women
general public
|
|
gptkbp:target_audience
|
gptkb:athletes
|
|
gptkbp:used_for
|
muscle growth
|
|
gptkbp:used_in
|
animal studies
|
|
gptkbp:weight
|
350.47 g/mol
|
|
gptkbp:bfsParent
|
gptkb:RD-500_rocket_engine
|
|
gptkbp:bfsLayer
|
7
|